These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 38276313)

  • 1. The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression.
    Cabała S; Ożgo M; Herosimczyk A
    Metabolites; 2024 Jan; 14(1):. PubMed ID: 38276313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Dobrek Ł
    Pol Merkur Lekarski; 2022 Oct; 50(299):323-327. PubMed ID: 36283018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
    Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease and gut microbiota.
    Amini Khiabani S; Asgharzadeh M; Samadi Kafil H
    Heliyon; 2023 Aug; 9(8):e18991. PubMed ID: 37609403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.
    Dobrek Ł
    Wiad Lek; 2022; 75(7):1757-1764. PubMed ID: 35962694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
    Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
    Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease.
    Huang Y; Xin W; Xiong J; Yao M; Zhang B; Zhao J
    Front Pharmacol; 2022; 13():837500. PubMed ID: 35370631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease.
    Altamura S; Pietropaoli D; Lombardi F; Del Pinto R; Ferri C
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet.
    Ikee R; Sasaki N; Yasuda T; Fukazawa S
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis in AKI to CKD transition.
    Saranya GR; Viswanathan P
    Biomed Pharmacother; 2023 May; 161():114447. PubMed ID: 37002571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease.
    Jazani NH; Savoj J; Lustgarten M; Lau WL; Vaziri ND
    Diseases; 2019 Feb; 7(1):. PubMed ID: 30781823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
    Lohia S; Vlahou A; Zoidakis J
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.
    Coutinho-Wolino KS; Melo MFS; Mota JC; Mafra D; Guimarães JT; Stockler-Pinto MB
    Nutr Rev; 2024 Jan; 82(2):248-261. PubMed ID: 37164634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: A focus on dietary fibers.
    Melekoglu E; Samur FG
    Crit Rev Food Sci Nutr; 2023; 63(19):3994-4008. PubMed ID: 34704501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.